SGLT2 Inhibitor Invokana & Farxiga Lawsuit

SGLT2 Inhibitors - Invokana & Farxiga Lawsuit

Since the FDA warned of the connection of SGLT2 inhibitors and ketoacidosis, many Jardiance, Invokana, Farxiga lawsuits are expected to be filed against manufacturers of these drugs. These drugs are intended to treat Type II diabetes by lowering blood sugar levels. However, these drugs also cause a dangerous condition called diabetic ketoacidosis (DKA) in Type II diabetics. The FDA released their official warning after discovering 20 cases of ketoacidosis in Type II diabetes patients while taking SGLT2 inhibitors. The FDA urges any patients with Type II diabetes who have been diagnosed with ketoacidosis while taking SGLT2 inhibitors to come forward so the FDA can assess the risks of SGLT2 inhibitors. If you’ve suffered from ketoacidosis while taking SGLT2 inhibitors, join others who are now filing lawsuits and help protect others from the dangers of ketoacidosis.